R, H. (2026). Monoclonal Antibody Therapy in Early Alzheimer’s disease: a Review of Lecanemab and Aducanumab. Biospecia, 2(1), 1–6. Retrieved from https://uniquepubinternational.com/journals/index.php/biospecia/article/view/182